PHOENIX-OITB Launches Open Call Offering Funded Services in Nanopharmaceutical Development
On 10 October 2022, PHOENIX-OITB launched an Open Call, offering funded services in nanopharmaceutical development to a broad audience. The services and expertise provided by the PHOENIX-OITB include production and characterisation under GMP conditions, safety evaluation, regulatory compliance and commercialisation boost. Under the scope of the Open Call, we offer the following service categories:
- Physico-Chemical Characterization,
- In vitro Characterisation,
- In vivo Characterisation and
- Manufacturing
Any legal entity (SMEs, start up or RTOs) and research group, based in the European Union or associate countries of H2020 can apply to this call.
First-stage applications are due 31 Jan 2023.
To view the complete call and download all application documents, visit the dedicated Open Call page on our website below.
